Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)
HCPCS code
Name of the Procedure:
Influenza Virus Vaccine, Split Virus, When Administered to Individuals 3 Years of Age and Older, for Intramuscular Use (Flulaval)
Common Name(s): Flu shot, Flulaval vaccination
Technical/Medical Term: Influenza vaccine, split virus, intramuscular administration
Summary
The Flulaval flu shot is a vaccination given to individuals aged 3 years and older to protect them from the influenza virus. The vaccine is administered as an injection into a muscle, typically in the upper arm.
Purpose
The flu shot is designed to prevent influenza, a contagious respiratory illness caused by influenza viruses. The primary goal is to reduce the risk of flu-related complications, hospitalizations, and severe illness by boosting the immune system's ability to fight off the virus.
Indications
- Individuals aged 3 years and older
- Persons with chronic health conditions (e.g., asthma, diabetes, heart disease)
- Elderly individuals or those with weakened immune systems
- Healthcare workers and caregivers
- Pregnant women
Preparation
- No fasting is required.
- Inform your healthcare provider of any allergies, especially to eggs or previous flu vaccines.
- Wear clothing with easy access to the upper arm.
- Ensure you're not currently ill with a fever or acute infection.
Procedure Description
- The healthcare provider explains the procedure and addresses any concerns.
- The patient is seated, and the upper arm is exposed.
- The provider cleans the injection site with an alcohol swab.
- Using a sterile syringe, the provider administers the vaccine intramuscularly into the deltoid muscle of the upper arm.
- The injection site is covered with a band-aid, and post-vaccine care instructions are provided.
Tools/Equipment: Sterile syringe, alcohol swab, band-aid
Anesthesia/Sedation Details: None required
Duration
The injection takes only a few seconds, while the entire process, including preparation and post-injection observation, typically takes about 10-15 minutes.
Setting
The procedure is usually performed in outpatient settings such as doctors' offices, clinics, or pharmacies.
Personnel
- Nurses
- Healthcare providers (e.g., doctors, physician assistants)
Risks and Complications
Common Risks:
- Soreness, redness, or swelling at the injection site
- Mild fever
- Muscle aches
Rare Risks:
- Severe allergic reactions (anaphylaxis)
- Guillain-Barré Syndrome (an extremely rare neurological condition)
Management of Complications:
- Over-the-counter pain relievers for mild symptoms
- Immediate medical attention for severe allergic reactions
Benefits
- Reduced risk of contracting influenza
- Decreased likelihood of severe flu symptoms and complications
- Reduced spread of influenza within communities
Benefit Realization: Benefits typically begin about two weeks post-vaccination.
Recovery
- Patients can resume normal activities immediately after receiving the vaccine.
- Monitor the injection site for any signs of adverse reactions.
- Follow-up appointments are not typically necessary unless complications arise.
Alternatives
- Nasal spray flu vaccine (for eligible individuals)
Antiviral medications (for treating influenza, not for prevention)
Pros of Flulaval: High efficacy, widely available
Cons of Alternatives: Limited to specific age groups, underlying conditions, or not as effective as preventive measures
Patient Experience
During the procedure, patients may feel a brief pinch or sting at the injection site. Post-injection, there might be mild soreness or redness, which usually resolves within a few days. Over-the-counter pain relievers can help manage discomfort, and staying hydrated aids overall recovery.